Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

ClinicalTrials.gov ID: NCT07335601

Public ClinicalTrials.gov record NCT07335601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate MGL-3196 (Resmetirom) in Patients With MASH Who Have Undergone Liver Transplant for MASH Cirrhosis or Other Etiologies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2 double-blind, randomized, placebo-controlled study to evaluate resmetirom in 2 cohorts of subjects with moderate to advanced fibrosis, consistent with stage F2 and F3 fibrosis, who have undergone liver transplant. Cohort 1 will consist of patients who have undergone liver transplant for MASH cirrhosis who developed recurrent MASH. Cohort 2 will consist of subjects who have undergone liver transplant for indications other than MASH cirrhosis who developed de novo MASH.

Study identification

NCT ID
NCT07335601
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Madrigal Pharmaceuticals, Inc.
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 28, 2025
Primary completion
Jul 31, 2028
Completion
Feb 28, 2029
Last update posted
Aug 25, 2026

2025 – 2029

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
University of California San Diego La Jolla California 92037 Recruiting
University of California Los Angeles Medical Center Los Angeles California 90095 Not yet recruiting
University of California, San Francisco San Francisco California 94143 Recruiting
University of Colorado Aurora Colorado 80045 Recruiting
Medstar Georgetown University Hospital Washington D.C. District of Columbia 20007 Not yet recruiting
Northwestern University Chicago Illinois 60208 Recruiting
The University of Chicago Medicine Chicago Illinois 60637 Not yet recruiting
Mayo Clinic Rochester Minnesota 55905 Recruiting
University of Nebraska Omaha Nebraska 68198-2000 Not yet recruiting
Northwell Health Inc, Center for Liver Disease and Transplantation Manhasset New York 11030 Recruiting
NY Presbyterian- Weill Cornell Medicine New York New York 10065 Recruiting
Vanderbilt University Medical Center (VUMC) Nashville Tennessee 37212 Recruiting
Dallas Methodist Dallas Texas 75203 Recruiting
Houston Methodist Hospital Houston Texas 77030 Recruiting
Intermountain Medical Center Murray Utah 84107 Recruiting
University of Virginia Health System Charlottesville Virginia 22903 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07335601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07335601 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →